TQB3205

TQB3205 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3205, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors [Phase 1]